| Pharmaceutical items with modified prescription circumstances during COVID-19 pandemic |
| Listed drug | Form | Manner of administration |
| Abatacept | Injection 125 mg in 1 mL single dose autoinjector | Injection |
| Abatacept | Injection 125 mg in 1 mL single dose pre‑filled syringe | Injection |
| Abatacept | Powder for I.V. infusion 250 mg | Injection |
| Adalimumab | Injection 20 mg in 0.4 mL pre‑filled syringe | Injection |
| Adalimumab | Injection 40 mg in 0.8 mL pre‑filled syringe | Injection |
| Adalimumab | Injection 40 mg in 0.8 mL pre‑filled syringe, 6 | Injection |
| Adalimumab | Injection 40 mg in 0.8 mL pre‑filled pen | Injection |
| Adalimumab | Injection 40 mg in 0.8 mL pre‑filled pen, 4 | Injection |
| Adalimumab | Injection 40 mg in 0.8 mL pre‑filled pen, 6 | Injection |
| Ambrisentan | Tablet 5 mg | Oral |
| Ambrisentan | Tablet 10 mg | Oral |
| Baricitinib | Tablet 2 mg | Oral |
| Baricitinib | Tablet 4 mg | Oral |
| Benralizumab | Injection 30 mg in 1 mL single dose pre‑filled syringe | Injection |
| Benralizumab | Injection 30 mg in 1 mL single dose pre‑filled pen | Injection |
| Bosentan | Tablet 62.5 mg (as monohydrate) | Oral |
| Bosentan | Tablet 125 mg (as monohydrate) | Oral |
| Certolizumab pegol | Injection 200 mg in 1 mL single use pre‑filled syringe | Injection |
| Certolizumab pegol | Solution for injection 200 mg in 1 mL pre‑filled pen | Injection |
| Dornase alfa | Solution for inhalation 2.5 mg (2,500 units) in 2.5 mL | Inhalation |
| Epoprostenol | Powder for I.V. infusion 500 micrograms (as sodium) | Injection |
| Epoprostenol | Powder for I.V. infusion 500 micrograms (as sodium) with 2 vials diluent 50 mL | Injection |
| Epoprostenol | Powder for I.V. infusion 1.5 mg (as sodium) | Injection |
| Epoprostenol | Powder for I.V. infusion 1.5 mg (as sodium) with 2 vials diluent 50 mL | Injection |
| Etanercept | Injection set containing 4 vials powder for injection 25 mg and 4 pre‑filled syringes solvent 1 mL | Injection |
| Etanercept | Injection 50 mg in 1 mL single use auto‑injector, 4 | Injection |
| Etanercept | Injections 50 mg in 1 mL single use pre‑filled syringes, 4 | Injection |
| Golimumab | Injection 50 mg in 0.5 mL single use pre‑filled pen | Injection |
| Golimumab | Injection 50 mg in 0.5 mL single use pre‑filled syringe | Injection |
| Golimumab | Injection 100 mg in 1 mL single use pre‑filled pen | Injection |
| Guselkumab | Injection 100 mg in 1 mL single use pre‑filled syringe | Injection |
| Iloprost | Solution for inhalation 20 micrograms (as trometamol)
in 2 mL | Inhalation |
| Infliximab | Powder for I.V. infusion 100 mg | Injection |
| Ivacaftor | Sachet containing granules 50 mg | Oral |
| Ivacaftor | Sachet containing granules 75 mg | Oral |
| Ivacaftor | Tablet 150 mg | Oral |
| Ixekizumab | Injection 80 mg in 1 mL single dose pre‑filled pen | Injection |
| Lenalidomide | Capsule 5 mg | Oral |
| Lenalidomide | Capsule 10 mg | Oral |
| Lenalidomide | Capsule 15 mg | Oral |
| Lenalidomide | Capsule 25 mg | Oral |
| Lumacaftor with ivacaftor | Sachet containing granules, lumacaftor 100 mg and ivacaftor 125 mg | Oral |
| Lumacaftor with ivacaftor | Sachet containing granules, lumacaftor 150 mg and ivacaftor 188 mg | Oral |
| Lumacaftor with ivacaftor | Tablet containing lumacaftor 100 mg with ivacaftor 125 mg | Oral |
| Lumacaftor with ivacaftor | Tablet containing lumacaftor 200 mg with ivacaftor 125 mg | Oral |
| Macitentan | Tablet 10 mg | Oral |
| Mannitol | Pack containing 280 capsules containing powder for inhalation 40 mg and 2 inhalers | Inhalation by mouth |
| Mepolizumab | Powder for injection 100 mg | Injection |
| Mepolizumab | Injection 100 mg in 1 mL single dose pre-filled pen | Injection |
| Montelukast | Tablet, chewable, 4 mg (as sodium) | Oral |
| Montelukast | Tablet, chewable, 5 mg (as sodium) | Oral |
| Nintedanib | Capsule 100 mg | Oral |
| Nintedanib | Capsule 150 mg | Oral |
| Omalizumab | Injection 75 mg in 0.5 mL single dose pre‑filled syringe | Injection |
| Omalizumab | Injection 150 mg in 1 mL single dose pre‑filled syringe | Injection |
| Pirfenidone | Capsule 267 mg | Oral |
| Pirfenidone | Tablet 267 mg | Oral |
| Pirfenidone | Tablet 801mg | Oral |
| Pomalidomide | Capsule 3 mg | Oral |
| Pomalidomide | Capsule 4 mg | Oral |
| Riociguat | Tablet 500 micrograms | Oral |
| Riociguat | Tablet 1 mg | Oral |
| Riociguat | Tablet 1.5 mg | Oral |
| Riociguat | Tablet 2 mg | Oral |
| Riociguat | Tablet 2.5 mg | Oral |
| Risankizumab | Injection 75 mg in 0.83 mL pre‑filled syringe | Injection |
| Rituximab | Solution for I.V. infusion 500 mg in 50 mL | Injection |
| Secukinumab | Injection 150 mg in 1 mL pre‑filled pen | Injection |
| Sildenafil | Tablet 20 mg (as citrate) | Oral |
| Somatropin | Injection 0.4 mg (1.2 i.u.) with diluent in single use syringe (without preservative) | Injection |
| Somatropin | Injection 0.6 mg (1.8 i.u.) with diluent in single use syringe (without preservative) | Injection |
| Somatropin | Injection 0.8 mg (2.4 i.u.) with diluent in single use syringe (without preservative) | Injection |
| Somatropin | Injection 1 mg (3 i.u.) with diluent in single use syringe (without preservative) | Injection |
| Somatropin | Injection 1.2 mg (3.6 i.u.) with diluent in single use syringe (without preservative) | Injection |
| Somatropin | Injection 1.4 mg (4.2 i.u.) with diluent in single use syringe (without preservative) | Injection |
| Somatropin | Injection 1.6 mg (4.8 i.u.) with diluent in single use syringe (without preservative) | Injection |
| Somatropin | Injection 1.8 mg (5.4 i.u.) with diluent in single use syringe (without preservative) | Injection |
| Somatropin | Injection 2 mg (6 i.u.) with diluent in single use syringe (without preservative) | Injection |
| Somatropin | Injection 4 mg (12 i.u.) vial with diluent (with preservative) | Injection |
| Somatropin | Injection 18 i.u. (6 mg) cartridge with 3.15 mL diluent (with preservative) | Injection |
| Somatropin | Injection 72 i.u. (24 mg) cartridge with 3.15 mL diluent (with preservative) | Injection |
| Somatropin | Powder for injection 5 mg (15 i.u.) with diluent in pre‑filled pen (with preservative) | Injection |
| Somatropin | Powder for injection 12 mg (36 i.u.) with diluent in pre‑filled pen (with preservative) | Injection |
| Somatropin | Injection 36 i.u. (12 mg) cartridge with 3.15 mL diluent (with preservative) | Injection |
| Somatropin | Solution for injection 5 mg (15 i.u.) in 1.5 mL cartridge (with preservative) in pre‑filled pen | Injection |
| Somatropin | Solution for injection 5 mg (15 i.u.) in 1.5 mL cartridge (with preservative) | Injection |
| Somatropin | Solution for injection 6 mg (18 i.u.) in 1.03 mL cartridge (with preservative) | Injection |
| Somatropin | Solution for injection 10 mg (30 i.u.) in 1.5 mL cartridge (with preservative) | Injection |
| Somatropin | Solution for injection 10 mg (30 i.u.) in 1.5 mL cartridge (with preservative) in pre‑filled pen | Injection |
| Somatropin | Solution for injection 10 mg (30 i.u.) in 2 mL cartridge (with preservative) | Injection |
| Somatropin | Solution for injection 12 mg (36 i.u.) in 1.5 mL cartridge (with preservative) | Injection |
| Somatropin | Solution for injection 15 mg (45 i.u.) in 1.5 mL cartridge (with preservative) | Injection |
| Somatropin | Solution for injection 15 mg (45 i.u.) in 1.5 mL cartridge (with preservative) in pre‑filled pen | Injection |
| Somatropin | Solution for injection 20 mg (60 i.u.) in 2.5 mL cartridge (with preservative) | Injection |
| Tadalafil | Tablet 20 mg | Oral |
| Tezacaftor with ivacaftor and ivacaftor | Pack containing 28 tablets tezacaftor 100 mg with ivacaftor 150 mg and 28 tablets ivacaftor 150 mg | Oral |
| Tildrakizumab | Injection 100 mg in 1 mL single dose pre‑filled syringe | Injection |
| Tocilizumab | Concentrate for injection 80 mg in 4 mL | Injection |
| Tocilizumab | Concentrate for injection 200 mg in 10 mL | Injection |
| Tocilizumab | Concentrate for injection 400 mg in 20 mL | Injection |
| Tocilizumab | Injection 162 mg in 0.9 mL single use pre‑filled pen | Injection |
| Tocilizumab | Injection 162 mg in 0.9 mL single use pre‑filled syringe | Injection |
| Tofacitinib | Tablet 5 mg | Oral |
| Upadacitinib | Tablet 15 mg | Oral |
| Ustekinumab | Injection 45 mg in 0.5 mL | Injection |
| Ustekinumab | Solution for I.V. infusion 130 mg in 26 mL | Injection |
| Vedolizumab | Powder for injection 300 mg | Injection |